Filter News
Area of Research
News Topics
- (-) Biomedical (4)
- (-) Computer Science (5)
- (-) Machine Learning (1)
- (-) Physics (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (3)
- Artificial Intelligence (1)
- Bioenergy (3)
- Biology (1)
- Chemical Sciences (2)
- Climate Change (1)
- Composites (1)
- Coronavirus (5)
- Decarbonization (1)
- Energy Storage (1)
- Environment (2)
- Fusion (2)
- High-Performance Computing (1)
- Isotopes (3)
- Materials (2)
- Materials Science (1)
- Molten Salt (1)
- Nanotechnology (3)
- Neutron Science (1)
- Nuclear Energy (9)
- Space Exploration (1)
- Summit (3)
- Sustainable Energy (3)
- Transformational Challenge Reactor (1)
- Transportation (1)
Media Contacts
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
As a teenager, Kat Royston had a lot of questions. Then an advanced-placement class in physics convinced her all the answers were out there.
Researchers at the Department of Energy’s Oak Ridge National Laboratory have used Summit, the world’s most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.